Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001897612-25-000541
Filing Date
2025-11-14
Accepted
2025-11-14 12:18:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5707
  Complete submission text file 0001897612-25-000541.txt   7312
Mailing Address 450 ELANCO CIRCLE INDIANAPOLIS IN 46221
Business Address 450 ELANCO CIRCLE INDIANAPOLIS IN 46221 877-352-6261
Elanco Animal Health Inc (Subject) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90921 | Film No.: 251483357
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1307 POINT STREET BALTIMORE MD 21231
Business Address 1307 POINT STREET BALTIMORE MD 21231 000-000-0000
T. Rowe Price Investment Management, Inc. (Filed by) CIK: 0001897612 (see all company filings)

EIN.: 854328500 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13G